AKR1A1 expression increases following radiation of laryngeal cancer, thereby inhibiting the activation of p53; thus, AKR1A1 plays a role in acquired radiation resistance in laryngeal cancer cells [54]. Here, TP53 is linked to laryngeal carcinoma.